Fiorentino, F. and Di Rienzo, P. (2023) “Budget impact analysis of enzalutamide for the treatment of hormone-sensitive metastatic prostate cancer in Italy”, Global and Regional Health Technology Assessment, 10(1), pp. 29–39. doi: 10.33393/grhta.2023.2507.